$25 could help provide vital support for patients and whānau affected by stomach cancer.
Sign Up to Show Your Support
Support Gut Cancer Foundation in getting Kiwis with stomach cancer equitable access to treatment.
Stay updated on stomach cancer funding, research, news and advocacy.
400+
Over 400 people are diagnosed with stomach cancer in NZ every year.
3x
Māori are 3 times more likely to develop stomach cancer than NZ European communities.
47%
Around 47% of stomach cancer is diagnosed in an emergency setting.
How do we help Kiwis affected by stomach cancer?
Gut Cancer Foundation gives grants to New Zealand institutions from the funds we raise. They run clinical research, trials and fellowships with the goal of improving treatment for patients with gut cancers. Gut Cancer Foundation is currently actively supporting six studies and trials. Learn more about the stomach cancer trials and studies we are supporting.
Understanding Māori perspectives: tissue being used for living tissue models
New Zealand Research Study (in recruitment)
Francesca Munro (Ngāpuhi, Ngāti Moerewa, Ngāti Rangi), a PhD scholar funded by GCF at the University of Otago, is working to better understand gastric cancer sub-types in Aotearoa. Her research involves kōrero with Māori Health Providers and whānau in Te Tai Tokerau to explore culturally safe ways of using genetic sub-typing and tissue-based models to identify which treatments work best for different cancer sub-types. This work aims to ensure Māori are included in, and benefit from, future advances in gastric cancer care.
Ambulatory Holter Monitoring Feasibility Study
New Zealand Research Study (in recruitment)
GCF donors are supporting a feasibility study investigating the use of ambulatory Holter monitoring to detect silent heart issues in patients receiving 5-FU chemotherapy - one of the most common treatments for gut cancers. Currently recruiting 10 patients in Auckland, the study aims to assess whether continuous ECG monitoring during at-home chemotherapy infusions can identify early signs of cardiotoxicity. Since there are no PHARMAC-funded alternatives if 5-FU must be discontinued due to heart complications, early detection is critical.
TOPGEAR
International Research study (in findings stage)
GCF has contributed $17,520 to support the international TOPGEAR clinical trial, which is investigating whether adding radiation to chemotherapy before surgery improves outcomes for stomach cancer patients. Involving over 70 centres worldwide - including hospitals in Auckland, Christchurch, Dunedin, and Waikato. The study compares standard chemotherapy with a combination of chemo and radiation before surgery. GCF funding helped Auckland City Hospital continue recruiting patients into the trial’s final phase. With recruitment now complete, results will soon be shared, including an update at the ASTRO Annual Meeting in October.
Make a Donation
Help Kiwis affected by stomach cancer
Every Action Counts
By donating, raising awareness, or educating your whānau about stomach cancer, you can make a real impact in the lives of New Zealanders. Join us in sharing vital information and providing real support to those affected.
Every action counts - let’s make a difference together.
Donate to GCF today
We appreciate any support you can give to help fund clinical research and raise awareness of gut cancers.